Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Noah S Rozich

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7816-2275; OpenAlex author ID A5070343470. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
51
Papers, trials and grants by year

2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 8

  1. Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. Co-author DOI 10.1186/s13045-024-01576-z↗
  2. Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. First author DOI 10.1016/j.canlet.2022.215722↗
  3. CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. Co-author DOI 10.1084/jem.20211631↗
  4. Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003570↗
  5. CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2214/ajr.20.23490↗
  6. Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000004200↗
  7. A Qualitative Review of Neoadjuvant Chemotherapy in Resectable Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001376↗
  8. Malnutrition, frailty, and sarcopenia in pancreatic cancer patients: assessments and interventions for the pancreatic surgeon. Co-author DOI 10.21037/apc.2019.02.01↗

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alex B. Blair · 5 shared papers, 2019–2024 · strength 0.61
  2. Lei Zheng · 4 shared papers, 2021–2024 · strength 0.51
  3. Jin Peng He · 4 shared papers, 2020–2022 · strength 0.43
  4. Brian T. Herbst · 3 shared papers, 2022–2024 · strength 0.40
  5. Nan Niu · 3 shared papers, 2022–2024 · strength 0.40
  6. Keyu Li · 3 shared papers, 2022–2024 · strength 0.40
  7. Richard Andrew Burkhart · 3 shared papers, 2019–2021 · strength 0.34
  8. Christopher Lee Wolfgang · 3 shared papers, 2020–2021 · strength 0.32
  9. Junke Wang · 2 shared papers, 2022–2024 · strength 0.28
  10. Arsen Osipov · 2 shared papers, 2022–2024 · strength 0.28
  11. Stephen T. Muth · 2 shared papers, 2022 · strength 0.24
  12. Yao Xu · 2 shared papers, 2022 · strength 0.24
  13. Ammar A. Javed · 2 shared papers, 2020–2021 · strength 0.20
  14. Katherine Teresa Morris · 1 shared paper, 2019 · strength 0.16
  15. Mengni He · 1 shared paper, 2024 · strength 0.16
  16. Noelle R. Jurcak · 1 shared paper, 2024 · strength 0.16
  17. Xu-Bao Liu · 1 shared paper, 2024 · strength 0.16
  18. Chunhui Yuan · 1 shared paper, 2024 · strength 0.16
  19. Rebecca A. Sorber · 1 shared paper, 2019 · strength 0.14
  20. Jianxin Wang · 1 shared paper, 2022 · strength 0.12
  21. Pan Li · 1 shared paper, 2022 · strength 0.12
  22. Barish H. Edil · 1 shared paper, 2022 · strength 0.12
  23. Tingbo Liang · 1 shared paper, 2022 · strength 0.12
  24. Christopher L. Wolfgang · 1 shared paper, 2022 · strength 0.12
  25. Alan Yuille · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.